Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC MRS2500 tetraammonium | 630103-23-0 | 99.9% | 629.28 | 1 ML
SDP

Catalog No. 5000345248
Encompass_Preferred

MRS2500 tetraammonium is a potent, selective, and stable antagonist of the P2Y1 receptor (Ki=0.78 nM for recombinant human P2Y1 receptor). It inhibits the ADP-induced aggregation of human platelets with an IC50 value of 0.95 nM, demonstrating antithrombotic activity.

  • Potent, selective, and stable antagonist of the P2Y1 receptor.
  • Inhibits ADP-induced aggregation of human platelets with an IC50 of 0.95 nM.
  • Exhibits antithrombotic activity.
  • Decreases acute systemic thromboembolism through selective inhibition of the P2Y1 receptor.
  • Showed strong antithrombotic efficacy in preventing arterial thrombosis in the monkey ECAT model.

Catalog No. 50-003-45248 Supplier Medchemexpress LLC Supplier No. HY1086582MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MRS2500 tetraammonium is a potent, selective, and stable antagonist of the P2Y1 receptor (Ki=0.78 nM for recombinant human P2Y1 receptor). It inhibits the ADP-induced aggregation of human platelets with an IC50 value of 0.95 nM, demonstrating antithrombotic activity.

  • Potent, selective, and stable antagonist of the P2Y1 receptor.
  • Inhibits ADP-induced aggregation of human platelets with an IC50 of 0.95 nM.
  • Exhibits antithrombotic activity.
  • Decreases acute systemic thromboembolism through selective inhibition of the P2Y1 receptor.
  • Showed strong antithrombotic efficacy in preventing arterial thrombosis in the monkey ECAT model.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.